A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Popular cities in Texas
With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.
Why choose Texas for clinical trials?
Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.
By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.
Common conditions studied in Texas
Clinical trials in Texas cover a broad range of health conditions, offering participants the opportunity to contribute to medical advancements while accessing innovative treatments.
Cancer
Texas is home to world-leading cancer research institutions, making it a key location for oncology trials. These trials offer access to innovative treatments, such as new drugs, immunotherapies, and advanced radiation techniques that are not yet widely available.
As a major center for oncology research, Texas conducts clinical trials that cover a broad spectrum of cancers, including breast cancer, lung cancer, leukemia, colorectal cancer, prostate cancer, and liver cancer. These trials emphasize the development of targeted therapies, advancements in immunotherapy, and the exploration of combination treatments to improve the effectiveness of current cancer treatments.
Neurological disorders
Texas plays a major role in researching treatments for neurological conditions, particularly in areas such as stroke prevention, Alzheimer’s disease, Parkinson's disease, epilepsy, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
Clinical trials in these areas focus on developing innovative therapies, such as new drugs, brain stimulation devices, and gene therapies, with the goal of slowing disease progression and improving early intervention strategies.
Cardiovascular diseases
Heart disease is a leading cause of death across the United States, making cardiovascular clinical trials a top priority in Texas. These studies investigate conditions such as heart failure, coronary artery disease, hypertension, and atrial fibrillation.
Research centers are dedicated to developing new treatments and improving preventative measures to combat this widespread health issue, with the goal of reducing its impact on millions of people. Innovations being tested include next-generation heart devices, new cholesterol-lowering medications, and minimally invasive cardiovascular procedures, all aimed at reducing the impact of these conditions on the population.
Chronic conditions
Chronic conditions such as diabetes and obesity are significant health challenges across the United States. Clinical trials in Texas are essential for advancing the management and treatment of these widespread issues.
These trials play an important role in evaluating new diabetes medications, exploring weight-loss therapies, and developing advanced treatments for respiratory and kidney diseases. By focusing on these areas, Texas contributes to improving care and outcomes for long-term health conditions like Type 1 and Type 2 diabetes, asthma, and chronic obstructive pulmonary disease (COPD).
Infectious diseases
Infectious diseases remain a critical area of study in Texas, especially given the state’s role in COVID-19 vaccine research and other viral disease treatments. Several prominent research institutions and hospitals in Texas, such as The University of Texas Medical Branch (UTMB) in Galveston, Baylor College of Medicine in Houston, and the Texas Biomedical Research Institute in San Antonio, were involved in key phases of vaccine trials.
In addition to its significant role in the initial development of COVID-19 vaccines, clinical trials in the state are also focusing on several key areas such as evaluating the efficacy of antiviral drugs, and exploring new strategies for HIV/AIDS prevention. Research efforts also encompass other important areas such hepatitis C, tuberculosis, and influenza, aiming to improve treatments and prevention methods for these prevalent infectious diseases.
Mental health and behavioral disorders
With rising awareness of mental health challenges, Texas is a growing center for clinical research aimed at improving treatment options for psychiatric and behavioral disorders. Clinical trials explore both pharmaceutical solutions and therapeutic interventions.
Clinical trials address conditions such as depression, anxiety disorders, PTSD, schizophrenia, and bipolar disorder. These studies focus on testing novel antidepressants, anxiety-reducing therapies, and psychotherapies, aiming to provide better treatment options for individuals facing mental health challenges.
Rare diseases
Texas also supports clinical trials for rare diseases, offering new hope to patients with conditions that have limited treatment options. These studies often focus on genetic conditions and explore groundbreaking treatments like gene therapy.
Clinical trials cover conditions such as cystic fibrosis, Duchenne muscular dystrophy, rare cancers, and other inherited disorders. Research efforts focus on gene editing, enzyme replacement therapies, and drug development, pushing forward groundbreaking treatments for these often overlooked diseases.
Local regulations and guidelines
In Texas, clinical trials are governed by strict local regulations and guidelines to ensure the highest standards of safety and ethics. The Texas Department of State Health Services oversees clinical trials to ensure they adhere to state and federal standards. Researchers must obtain Institutional Review Board (IRB) approval, which involves a thorough review of the study’s design, risks, and benefits to protect participant welfare.
Informed consent is a crucial element for participants, ensuring they receive detailed information about the trial's purpose, procedures, potential risks, and benefits before agreeing to take part. Additionally, stringent privacy regulations are in place to protect the confidentiality of participants' medical information, upholding high standards of data security throughout the research process.
Benefits of participating in clinical trials
Participating in clinical trials offers numerous benefits, including access to cutting-edge treatments and therapies that are not yet available to the general public. Participants often receive close monitoring and care from top medical professionals, ensuring a high level of attention and support throughout the study.
Additionally, involvement in clinical trials contributes to important medical research that can lead to advancements in treatment and care for future patients. By participating, individuals not only gain early access to potentially groundbreaking interventions but also play an important role in advancing scientific knowledge and improving healthcare outcomes for others.
Worried about the risks of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a clinical trial in Texas
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.